NUVECTIS PHARMA INC's ticker is and the CUSIP is 67080T108. A total of 38 filers reported holding NUVECTIS PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STATE STREET CORP | 105,240 | $1,680,683 | 0.00% |
| NEW YORK STATE COMMON RETIREMENT FUND | 5,700 | $91 | 0.00% |
| STRS OHIO | 1,400 | $22 | 0.00% |
| CITIGROUP INC | 2,039 | $32,563 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 17,995 | $287,380 | 0.00% |
| MORGAN STANLEY | 5,103 | $81,496 | 0.00% |
| AMALGAMATED BANK | 1,039 | $17 | 0.00% |
| BANK OF MONTREAL /CAN/ | 11,012 | $199,978 | 0.00% |
| BlackRock Inc. | 314,491 | $5,022,421 | 0.00% |
| Bank of New York Mellon Corp | 19,150 | $305,826 | 0.00% |
| Nuveen Asset Management, LLC | 10,669 | $170,384 | 0.00% |
| Citadel Advisors | 28,028 | $447,607 | 0.00% |
| MetLife Investment Management, LLC | 3,970 | $63,401 | 0.00% |
| Tower Research Capital LLC (TRC) | 543 | $8,672 | 0.00% |
| JPMORGAN CHASE & CO | 5,460 | $87,196 | 0.00% |
| BARCLAYS PLC | 1,371 | $22 | 0.00% |
| ROYAL BANK OF CANADA | 2,692 | $43,000 | 0.00% |
| VANGUARD GROUP INC | 265,938 | $4,247,030 | 0.00% |
This page lists NUVECTIS PHARMA INC's shareholders in Q2 2023. To view NUVECTIS PHARMA INC's shareholder history, click here.